Follow-up monitoring of patients with liver cirrhosis by primary care physicians. Guidelines
https://doi.org/10.15829/3034-4123-2026-149
EDN: WGJZKB
Abstract
Liver cirrhosis remains one of the leading causes of mortality and disability among patients with gastrointestinal diseases. A significant proportion of cases are diagnosed at late stages, limiting effective treatment options and worsening the prognosis. The increasing incidence and high complication rate necessitate strengthening the primary care role in early detection, monitoring, and prevention of liver cirrhosis progression.
These guidelines systematize modern approaches to the management of patients with liver cirrhosis. The document presents diagnostic criteria, including clinical and paraclinical signs, as well as principles for a comprehensive patient assessment. A detailed follow-up algorithm is outlined, emphasizing the assessment of the patient's condition and the early decompensation detection. Particular attention is paid to the diagnosis and monitoring of complications (portal hypertension, ascites, hepatic encephalopathy, etc.), interpretation of laboratory parameters, and the use of diagnostic methods. The principles of non-drug and drug therapy, preventive counseling, vaccination, and referral criteria for hospitalization and liver transplantation are discussed.
This document is intended for general practitioners, gastroenterologists, and other primary care specialists involved in providing care to patients with liver cirrhosis.
About the Authors
O. M. Drapkina
National Medical Research Center for Therapy and Preventive Medicine; Russian University of Medicine
Russian Federation
Russian Federation
Petroverigsky Lane, 10, bld. 3, Moscow, 101990;
Dolgorukovskaya str., 4, Moscow, 127006
M. V. Maevskaya
I. M. Sechenov First Moscow State Medical University of the Ministry of Health of the Russian Federation (Sechenov University)
Russian Federation
Russian Federation
Trubetskaya str., 8, bld. 2, Moscow, 119991
R. N. Shepel
National Medical Research Center for Therapy and Preventive Medicine
Russian Federation
Russian Federation
Petroverigsky Lane, 10, bld. 3, Moscow, 101990
M. E. Zharova
National Medical Research Center for Therapy and Preventive Medicine
Russian Federation
Russian Federation
Petroverigsky Lane, 10, bld. 3, Moscow, 101990
V. R. Grechishnikova
I. M. Sechenov First Moscow State Medical University of the Ministry of Health of the Russian Federation (Sechenov University)
Russian Federation
Russian Federation
Trubetskaya str., 8, bld. 2, Moscow, 119991
References
1. Huang DQ, Terrault NA, Tacke F, et al. Global epidemiology of cirrhosis - aetiology, trends and predictions. Nat Rev Gastroenterol Hepatol. 2023;20(6):388-98. doi:10.1038/s41575-023-00759-2.
2. Ye F, Zhai M, Long J, et al. The burden of liver cirrhosis in mortality: Results from the global burden of disease study. Front Public Health. 2022;10:909455. doi:10.3389/fpubh.2022.909455.
3. Tham EKJ, Tan DJH, Danpanichkul P, et al. The Global Burden of Cirrhosis and Other Chronic Liver Diseases in 2021. Liver Int. 2025;45(3):e70001. doi:10.1111/liv.70001.
4. Zhang Y, Luo M, Ming Y. Global burden of cirrhosis and other chronic liver diseases caused by specific etiologies from 1990 to 2021. BMC Gastroenterol. 2025;25(1):641. doi:10.1186/s12876-025-04264-5.
5. GBD 2017 Cirrhosis Collaborators. The global, regional, and national burden of cirrhosis by cause in 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet Gastroenterol Hepatol. 2020;5(3):245-66. doi:10.1016/S2468-1253(19)30349-8.
6. Shepel RN, Ipatov PV, Drozdova LYu, et al. Algorithm of appointment (examination; consultation) of patients under follow-up care by a general practitioner. Cardiovascular Therapy and Prevention. 2025;24(3):4372. (In Russ.) doi:10.15829/1728-8800-2025-4372. EDN: JHOQVT.
7. Drapkina OM, Ivashkin VT, Maev IV, et al. Outpatient follow-up of patients with alcohol-associated liver cirrhosis by a primary care physician. Guidelines. Primary Health Care (Russian Federation). 2025;2(1):115-45. (In Russ.) doi:10.15829/3034-4123-2025-33. EDN: DQSXKB.
8. Sterling RK, Asrani SK, Levine D, et al. AASLD Practice Guideline on noninvasive liver disease assessment of portal hypertension. Hepatology. 2025;81(3):1060-85. doi:10.1097/HEP.0000000000000844.
9. Sterling RK, Duarte-Rojo A, Patel K, et al. AASLD Practice Guideline on imaging-based noninvasive liver disease assessment of hepatic fibrosis and steatosis. Hepatology. 2025;81(2):672-724. doi:10.1097/HEP.0000000000000843.
10. Kashin SV, Kuvaev RO, Drapkina OM, et al. Standards for performing eso phagogastroduodenoscopy (EGDS) in the framework of the medical examination program for certain groups of the adult population of the Russian Federation: Metho dological recommendations. Moscow: Silicea-Polygraph LLC, 2024. 58 p. (In Russ.) ISBN: 978-5-605-25981-7. doi:10.15829/ROPNIZ-k6-2024. EDN: IYLUGC.
11. Drapkina OM, Drozdova LYu, Kalinina AM, et al. Organization of preventive medical examination and medical examination of certain groups of the adult population: Methodological recommendations of the Federal State Budgetary Institution "NMIC TPM" of the Ministry of Health of the Russian Federation. 2nd edition. Moscow: National Medical Research Center for Therapy and Preventive Medicine, 2020. 232 p. (In Russ.) ISBN: 978-5-6043991-1-8. EDN QWHFZK.
12. Drapkina OM, Briko NI, Namazova-Baranova LS, et al. Immunoprophylaxis. Guidelines (second edition). Primary Health Care (Russian Federation). 2025;2(3):135-262. (In Russ.) doi:10.15829/3034-4123-2025-76. EDN: DBKJIQ.
13. Drapkina OM, Avalueva EB, Bakulin IG, et al. Management of patients with iron deficiency anemia in the context of primary health care. Guidelines. Primary Health Care (Russian Federation). 2025;2(3):55-114. (In Russ.) doi:10.15829/3034-4123-2025-61. EDN: UKRRDT.
14. Amarneh M, Akhter A, Rajput MZ, et al. Gallbladder Scalloping, Mammillated Caudate Lobe, and Inferior Vena Cava Scalloping: Three Novel Ultrasound Signs of Cirrhosis. Acad Radiol. 2018;25(11):1374-80. doi:10.1016/j.acra.2018.02.011.
15. Singal AG, Llovet JM, Yarchoan M, et al. AASLD Practice Guidance on prevention, diagnosis, and treatment of hepatocellular carcinoma. Hepatology. 2023;78(6):1922-65. doi:10.1097/HEP.0000000000000466. Erratum in: Hepatology. 2023;78(6):E105. doi:10.1097/HEP.0000000000000621.
16. Expert Panel on Gastrointestinal Imaging; Smith EN, Bashir MR, Fung A, et al. ACR Appropriateness Criteria® Staging and Follow-Up of Primary Liver Cancer. J Am Coll Radiol. 2025;22(11S):S699-S712. doi:10.1016/j.jacr.2025.08.032.
17. Lee YJ, Lee JM, Lee JS, et al. Hepatocellular carcinoma: diagnostic performance of multidetector CT and MR imaging-a systematic review and meta-analysis. Radiology. 2015;275(1):97-109. doi:10.1148/radiol.14140690.
18. European Association for the Study of the Liver. EASL Clinical Practice Guidelines on nutrition in chronic liver disease. J Hepatol. 2019;70(1):172-93. doi:10.1016/j.jhep.2018.06.024.
19. Plauth M, Bernal W, Dasarathy S, et al. ESPEN guideline on clinical nutrition in liver disease. Clin Nutr. 2019;38(2):485-521. doi:10.1016/j.clnu.2018.12.022.
20. Lukina YuV, Kutishenko NP, Martsevich SYu, Drapkina OM. The Questionnaire Survey Method in Medicine on the Example of Treatment Adherence Scales. Rational Pharmacotherapy in Cardiology. 2021;17(4):576-83. (In Russ.) doi:10.20996/1819-6446-2021-08-02.
Review
For citations:
Drapkina OM, Maevskaya MV, Shepel RN, Zharova ME, Grechishnikova VR. Follow-up monitoring of patients with liver cirrhosis by primary care physicians. Guidelines. Primary Health Care (Russian Federation). 2026;3(2S):6-58. (In Russ.) https://doi.org/10.15829/3034-4123-2026-149. EDN: WGJZKB
Views:
361
JATS XML
Email this article 